Literature DB >> 15692830

Single nucleotide polymorphisms of ABCB1 (MDR1) gene and distinct haplotype profile in a West Black African population.

Aurel C Allabi1, Yves Horsmans, Bouchra Issaoui, Jean-Luc Gala.   

Abstract

OBJECTIVE: The ABCB1 (MDR1) multidrug transporter plays a key role in determining drug bioavailability. Differences in drug response exist among different ethnic groups. However, until now, no haplotype data are available in a Black African population.
METHODS: Exons 2, 7, 10, 11, 12, 14, 17, 21, 26, and the surrounding intronic regions were sequenced using genomic DNA from 111 Beninese subjects to examine 19 intragenic single nucleotide polymorphisms (SNPs). Linkage disequilibrium analysis and haplotypes were generated using the expectation-maximization algorithm.
RESULTS: We identified 12 SNPs, 3 of which were novel: IVS9-57delA, IVS9-8T>A, 1662G>C (exon 14). The most common SNP was IVS14+38A>G. At the MRD1 locus, 53 haplotypes were inferred from the SNP data sets. The 4 SNPs, IVS6+139C>T, IVS9-44A>G, 1236C>T, and 3435C>T, showed strong linkage disequilibrium with each other, confirming the block concept. Moreover, our findings suggest that ABCB1 exonic SNPs are less frequently observed in our population than in African-Americans.
CONCLUSION: Our data are compatible with a close evolutionary relationship in Black Africans from Benin.

Entities:  

Mesh:

Year:  2005        PMID: 15692830     DOI: 10.1007/s00228-004-0879-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

1.  Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations.

Authors:  Kun Tang; Soo-Mun Ngoi; Pai-Chung Gwee; John M Z Chua; Edmund J D Lee; Samuel S Chong; Caroline G L Lee
Journal:  Pharmacogenetics       Date:  2002-08

Review 2.  P-glycoprotein and multidrug resistance.

Authors:  M M Gottesman; I Pastan; S V Ambudkar
Journal:  Curr Opin Genet Dev       Date:  1996-10       Impact factor: 5.578

3.  Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

Authors:  I Cascorbi; T Gerloff; A Johne; C Meisel; S Hoffmeyer; M Schwab; E Schaeffeler; M Eichelbaum; U Brinkmann; I Roots
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

4.  Statistical method for testing the neutral mutation hypothesis by DNA polymorphism.

Authors:  F Tajima
Journal:  Genetics       Date:  1989-11       Impact factor: 4.562

5.  Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects.

Authors:  S Ito; I Ieiri; M Tanabe; A Suzuki; S Higuchi; K Otsubo
Journal:  Pharmacogenetics       Date:  2001-03

6.  MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity.

Authors:  M M Ameyaw; F Regateiro; T Li; X Liu; M Tariq; A Mobarek; N Thornton; G O Folayan; J Githang'a; A Indalo; D Ofori-Adjei; D A Price-Evans; H L McLeod
Journal:  Pharmacogenetics       Date:  2001-04

Review 7.  Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs.

Authors:  Toshiyuki Sakaeda; Tsutomu Nakamura; Katsuhiko Okumura
Journal:  Pharmacogenomics       Date:  2003-07       Impact factor: 2.533

8.  Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene.

Authors:  Deanna L Kroetz; Christiane Pauli-Magnus; Laura M Hodges; Conrad C Huang; Michiko Kawamoto; Susan J Johns; Doug Stryke; Thomas E Ferrin; Joseph DeYoung; Travis Taylor; Elaine J Carlson; Ira Herskowitz; Kathleen M Giacomini; Andrew G Clark
Journal:  Pharmacogenetics       Date:  2003-08

9.  Haplotype analysis of ABCB1/MDR1 blocks in a Japanese population reveals genotype-dependent renal clearance of irinotecan.

Authors:  Kimie Sai; Nahoko Kaniwa; Masaya Itoda; Yoshiro Saito; Ryuichi Hasegawa; Kazuo Komamura; Kazuyuki Ueno; Shiro Kamakura; Masafumi Kitakaze; Kuniaki Shirao; Hironobu Minami; Atsushi Ohtsu; Teruhiko Yoshida; Nagahiro Saijo; Yutaka Kitamura; Naoyuki Kamatani; Shogo Ozawa; Jun-Ichi Sawada
Journal:  Pharmacogenetics       Date:  2003-12

10.  Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.

Authors:  S Hoffmeyer; O Burk; O von Richter; H P Arnold; J Brockmöller; A Johne; I Cascorbi; T Gerloff; I Roots; M Eichelbaum; U Brinkmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  8 in total

1.  Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Dhandapani Kayathiri; Subramanian Rajan; Deepak Gopal Shewade; Steven Aibor Dkhar; Sajjanavar Manjunath; Prayaga Ushakiran; Gangadharan Reneega; Kukreti Ritushree; Chandrasekaran Adithan
Journal:  Mol Biol Rep       Date:  2012-02-09       Impact factor: 2.316

2.  Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia.

Authors:  Hui He; Jiye Yin; Xi Li; Yu Zhang; Xiaojing Xu; Ming Zhai; Juan Chen; Chenyue Qian; Honghao Zhou; Zhaoqian Liu
Journal:  Eur J Clin Pharmacol       Date:  2015-01-09       Impact factor: 2.953

3.  Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event.

Authors:  Catherine Bourguinat; Joseph Kamgno; Michel Boussinesq; Charles D Mackenzie; Roger K Prichard; Timothy G Geary
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

4.  Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein).

Authors:  Laura M Hodges; Svetlana M Markova; Leslie W Chinn; Jason M Gow; Deanna L Kroetz; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-03       Impact factor: 2.089

5.  Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.

Authors:  T M Bosch; V D Doodeman; P H M Smits; I Meijerman; J H M Schellens; J H Beijnen
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

Review 6.  Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Chandrasekaran Adithan
Journal:  Indian J Med Res       Date:  2014-01       Impact factor: 2.375

Review 7.  Effect of MDR1 C1236T polymorphism on cyclosporine pharmacokinetics: A systematic review and meta-analysis.

Authors:  Zhe Chen; Lingli Zhang; Chunsong Yang; Zhimei Jiang; Hongxin Shen; Ge Gui
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

Review 8.  Genetic Diversity in Drug Transporters: Impact in African Populations.

Authors:  Iris Rajman; Laura Knapp; Imad Hanna
Journal:  Clin Transl Sci       Date:  2020-03-31       Impact factor: 4.689

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.